AstraZeneca (Australia)

Recent papers from AstraZeneca (Australia)

1. Adaptive CX3CR1-defined cd8 t-cell remodelling in non-ischaemic dilated cardiomyopathyEuropean Heart Journal · 2026
2. A Hybrid Mechanistic Model Capturing Lactate Run‐Away and Back‐Metabolism in Mammalian Cell CultureBiotechnology and Bioengineering · 2026
3. Treatment patterns and outcomes in US patients with unresectable HCC treated with embolizationHepatic Oncology · 2026
4. Monoclonal Antibody Coformulations Reveal Three Interaction Patterns Governing StabilityMolecular Pharmaceutics · 2026
5. Fundamental dynamical units for physics-informed structural inference from perturbation time-series in networked systemsScientific Reports · 2026
6. High Conservation of the Human Metapneumovirus Fusion Protein in Contemporary Global Sequences Supports Its Continued Relevance for Therapeutic and Prophylactic ConsiderationMicroorganisms · 2026
7. Population Pharmacokinetics and Exposure–response Analysis of Durvalumab in Patients with Limited-stage Small-cell Lung Cancer in the Phase 3 ADRIATIC StudyThe AAPS Journal · 2026
8. Radical Disconnection Logic Enables Direct Conversion of α-Amino Acids into Differentiated Vicinal DiaminesJournal of the American Chemical Society · 2026
9. In Vitro Exploration of Antisense and Splice-Switching Oligonucleotide Multimers Using an Engineered Peptide ScaffoldJournal of Medicinal Chemistry · 2026
10. Estimating cumulative incidence from partially missing time series of respiratory viral infectionsPLoS ONE · 2026
11. Leveraging neural network models for drug repurposing: a case study on cardiac hypertrophyScientific Reports · 2026
12. Tozorakimab to Prevent COPD ExacerbationsNew England Journal of Medicine · 2026
13. BONAFIDE: a Python framework for the calculation of local features for atoms and bonds in moleculesJournal of Cheminformatics · 2026
14. Beyond natural amino acids: extending immunogenicity risk assessment to modified peptides through chemical feature encoding. A case study on citrullinationFrontiers in Immunology · 2026
15. Safety, Pharmacokinetics, and Predicted Neutralizing Activity of the SARS-CoV-2 Monoclonal Antibody Sipavibart: Results from Little DIPPER and the SUPERNOVA SubstudyInfectious Diseases and Therapy · 2026
16. Healthcare resource utilisation and associated costs in patients with eosinophilic granulomatosis with polyangiitis in England: A retrospective observational cohort studyWorld Allergy Organization Journal · 2026
17. Oral Relaxin Receptor Agonist AZD5462 in Participants With Chronic Heart Failure: Primary Results From the LUMINARA TrialCirculation · 2026
18. Single-cell and in vivo profiling reveal heterogeneous and organ-specific CRISPR-Cas9 off-target and translocation outcomesNature Communications · 2026
19. Reductive Couplings Via Nucleophilic Photoactivation of CarbonylsJournal of the American Chemical Society · 2026
20. Sub-stoichiometric 5-methoxyuridine modification enables tunable immune evasion and protein expression from synthetic mRNAsMolecular Therapy — Nucleic Acids · 2026